OC
TYRA icon

Oppenheimer & Co’s Tyra Biosciences TYRA Stock Holding History

Oppenheimer & Co’s Portfolio TYRA Stock Details TYRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.22M Sell
84,192
-534
-0.6% -$17.3K 0.04% 448
2025
Q4 		$2.23M Buy
84,726
+2,488
+3% +$45.7K 0.03% 517
2025
Q3 		$1.15M Buy
82,238
+8,205
+11% +$93.6K 0.01% 828
2025
Q2 		$708K Sell
74,033
-772
-1% -$7.33K 0.01% 1008
2025
Q1 		$696K Sell
74,805
-634
-0.8% -$8.2K 0.01% 955
2024
Q4 		$1.05M Sell
75,439
-1,367
-2% -$24.8K 0.02% 765
2024
Q3 		$1.81M Buy
76,806
+6,318
+9% +$133K 0.03% 588
2024
Q2 		$1.13M Buy
70,488
+10,912
+18% +$188K 0.02% 727
2024
Q1 		$977K Buy
+59,576
New +$977K 0.02% 747

Other funds holding TYRA

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
APMC
Alta Partners Management Company Jackson, Wyoming $127M AUM 230.85% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return

Oppenheimer & Co's TYRA Position: Q1 2026 in Review

Oppenheimer & Co reduced its Tyra Biosciences (TYRA) stake by 0.63% in Q1 2026, selling an estimated $17.3K and leaving 84,192 shares worth $3.22M. The position accounts for 0.04% of the portfolio, ranked #448.

Oppenheimer & Co first reported a position in TYRA in Q1 2024 and has held it in 9 quarters since. 164 funds tracked by Wall St. Rank hold TYRA as of Q1 2026.

  • Oppenheimer & Co held 84,192 shares of Tyra Biosciences worth $3.22M as of Q1 2026.
  • Oppenheimer & Co sold 534 Tyra Biosciences shares in Q1 2026, an estimated $17.3K.
  • Tyra Biosciences made up 0.04% of Oppenheimer & Co's portfolio in Q1 2026, its #448 holding.
  • Oppenheimer & Co first reported a position in Tyra Biosciences in Q1 2024 and has held it in 9 quarters since.
  • 164 funds tracked by Wall St. Rank held Tyra Biosciences as of Q1 2026.

Based on Oppenheimer & Co's 13F filing for Q1 2026, filed 24 Apr 2026.